HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Psychosine (Galactosylsphingosine)

An intermediate in the biosynthesis of cerebrosides. It is formed by reaction of sphingosine with UDP-galactose and then itself reacts with fatty acid-Coenzyme A to form the cerebroside.
Also Known As:
Galactosylsphingosine; Galactoside, Sphingosine; Sphingosine Galactoside; beta-D-Galactopyranoside, 2-amino-3-hydroxy-4-octadecenyl, (R-(R*,S*-(E)))-
Networked: 188 relevant articles (9 outcomes, 19 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bongarzone, Ernesto R: 21 articles (01/2022 - 01/2011)
2. Sands, Mark S: 12 articles (01/2022 - 06/2010)
3. Jiang, Xuntian: 9 articles (01/2022 - 01/2009)
4. Singh, Inderjit: 9 articles (01/2015 - 05/2002)
5. Givogri, Maria I: 8 articles (01/2022 - 01/2011)
6. Nguyen, Duc: 7 articles (01/2022 - 01/2017)
7. van Breemen, Richard: 7 articles (01/2022 - 07/2011)
8. Lopez-Rosas, Aurora: 7 articles (01/2015 - 01/2011)
9. Singh, Avtar K: 7 articles (01/2015 - 05/2002)
10. Wrabetz, Lawrence: 6 articles (01/2022 - 11/2016)

Related Diseases

1. Globoid Cell Leukodystrophy (Krabbe Disease)
2. Demyelinating Diseases (Demyelinating Disease)
3. Neuroinflammatory Diseases
4. Inflammation (Inflammations)
5. Lysosomal Storage Diseases (Lysosomal Storage Disease)
11/01/2016 - "Because substrate inhibition therapy has been shown to be effective in some human lysosomal storage diseases, we hypothesize that a substrate inhibition therapeutic approach might be appropriate to allow correction of the imbalance between formation and breakdown of glycosphingolipids and to prevent pathological storage of psychosine. "
11/01/2016 - "Globoid cell leukodystrophy (GLD) is a lysosomal storage disease caused by β-galactosylceramidase (GALC) deficiency and characterized by the accumulation of the neurotoxic metabolite psychosine in the central nervous system and peripheral tissues. "
01/01/2023 - "We have shown in vivo and in vitro previously that psychosine causes dysfunction of autophagy and the ubiquitin-proteasome system underlying the pathogenesis of globoid cell leukodystrophy (GLD), a devastating lysosomal storage disease complicated by global demyelination. "
01/01/2022 - "Krabbe disease is a lysosomal storage disease caused by mutations in the gene that encodes galactosylceramidase, in which galactosylsphingosine (psychosine) accumulation drives demyelination in the central and peripheral nervous systems, ultimately progressing to death in early childhood. "
11/01/2016 - "Krabbe's disease, also known as globoid cell leukodystrophy (GLD), is a lysosomal storage disease caused by the deficiency of the lysosomal enzyme β-galactocerebrosidase (GALC), resulting in severe neurological manifestations related to demyelination secondary to elevated galactosylsphingosine (psychosine) with its subsequent cytotoxicity. "

Related Drugs and Biologics

1. Enzymes
2. Lipids
3. Glycosphingolipids
4. Secretory Phospholipases A2
5. Sphingolipids
6. Phorbol Esters
7. Free Radicals
8. Dimethyl Sulfoxide (DMSO)
9. Antioxidants
10. Psychosine (Galactosylsphingosine)

Related Therapies and Procedures

1. Therapeutics
2. Bone Marrow Transplantation (Transplantation, Bone Marrow)
3. Hematopoietic Stem Cell Transplantation
4. Enzyme Replacement Therapy
5. Cell Transplantation